Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

PepsiCo, Inc. (PEP), Mondelez International Inc (MDLZ): Maverick Investor Seeking A Merger?

With the recent disclosure that he had taken significant stakes in both PepsiCo, Inc. (NYSE:PEP) and Mondelez International Inc (NASDAQ:MDLZ), it is fair to speculate on the motives of maverick investor Nelson Peltz. Based on his previous experiences with well-known companies, it seems possible that he intends to leave his mark on both firms’ boards. Indeed, more dramatic moves might not be out of the question.

PepsiCo, Inc. (NYSE:PEP)Both of these companies find themselves at crucial inflection points. PepsiCo, Inc. (NYSE:PEP) is in the early stages of exploring spin-off options for its North American bottling operation, and Mondelez International Inc (NASDAQ:MDLZ) has under-performed market-watchers’ expectations since separating from Kraft (K) in 2012.

According to the most recent filing, Peltz’s Trian Fund Management now has a $270 million stake in PepsiCo, Inc. (NYSE:PEP) and a $494 million stake in Mondelez International Inc (NASDAQ:MDLZ). For Mondelez International Inc (NASDAQ:MDLZ), this equates to less than 1 percent of its market capitalization. For PepsiCo, Inc. (NYSE:PEP), Peltz’s stake represents little more than a rounding error however the fact that Peltz and PepsiCo, Inc. (NYSE:PEP) are already engaging in “strategic, long-term” discussions suggests that the investor has big plans for these firms.

PepsiCo and Mondelez at a Glance

PepsiCo, Inc. (NYSE:PEP) is a massive food and drink distributor that markets many recognizable brands. In addition to signature drinks like Pepsi and Gatorade, the company also sells a variety of breakfast cereals, snacks, coffees, teas and juices. Meanwhile, Chicago-based Mondelez International Inc (NASDAQ:MDLZ) primarily offers coffee and cracker products through brands like Nabisco, Cadbury and Oreo. It also markets Trident gum and Tang juice mixes.

The synergies between PepsiCo and Mondelez International Inc (NASDAQ:MDLZ) are obvious. The companies have plenty of redundant divisions that would mesh well together, and the prospect of a Pepsi drinks spin-off raises the possibility that the “dry foods” components of the two companies could combine in a merger. At this point, such a scenario is highly speculative. Nevertheless, investors cannot discount the obvious utility in combining similar pieces of these two companies.

Financial Comparisons

It might be useful to compare PepsiCo and Mondelez to determine whether the two are suitable merger partners. For starters, both companies are solidly profitable. In 2012, PepsiCo earned about $6.1 billion on $65.2 billion gross revenue and walked away with a profit margin of 9.3 percent. At over 27 percent, its return on equity figure was significantly better. Meanwhile, Mondelez earned $1.5 billion on $35 billion gross revenue for a final margin of 8.6 percent. Its return on equity figure of less than 5 percent left something to be desired.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.